ACADEMIC INFORMATION AND ADMISSIONS
Credits - 70 / European ECTS credits
Pre-selection process: Open
Inscriptions: from January 2019 to September 2019
Master Program – 14th October 2019 to 19th June 2020.
Full Time - Monday to Thursday from 18:00h. to 21:00h.
Language - English
The objective of the programme is to acquire the knowledge to develop biotech companies in drug discovery, knowledge transfer and capital increases to develop in early stage preclinical and clinical phases. The main skills and topics are related with financial statements, entrepreneurships, valuation models, venture funds, financing rounds and international relationships within the different stake holders in life sciences.
The students of our master programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers.
I. Global Ecosystem in Drug Discovery
II. Scientific and Regulatory Developemt
III. Profesional and Personal Leadership
IV. Biotechnology Based Companies
V. Venture Capital and Funding
VI. Master's Thesis - Drug Discovery Business Plan